Enanta Pharmaceuticals reported $1.48M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 33291M 4833M
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 28939M 4338M
Biogen BIIB:US $ 6272.3M 996.9M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Clovis Oncology CLVS:US $ 599.54M 16.41M
GlaxoSmithKline GSK:LN 20736M 294M
Halozyme Therapeutics HALO:US $ 786.45M 0.88M
Insmed INSM:US $ 571.41M 8.55M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Ligand Pharmaceuticals LGND:US $ 316.89M 1.57M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 24715M 1776M
Novavax NVAX:US $ 323.1M 8.84M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
YTE INCY:US $ 31.38M 0.46M